Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1983 Aug;36(8):873–882. doi: 10.1136/jcp.36.8.873

Blood group antigens in the normal and neoplastic bladder epithelium.

S J Thorpe, P Abel, G Slavin, T Feizi
PMCID: PMC498415  PMID: 6348100

Abstract

The indirect immunofluorescence technique was used to study the expression of the blood group A and H antigens in fresh-frozen and formalin-fixed paraffin-embedded sections of the bladder mucosa of 21 patients with non-neoplastic diseases of the bladder. Reliable assessment of these antigens could only be made using cryostat sections of fresh-frozen tissues. Also included in this study were tumour tissues of 5 patients with bladder cancer. The blood group A antigen was totally deleted in cryostat sections of the tumour of one patient with aggressive carcinoma and the appropriate antigens were diminished or focally deleted in the four patients with tumours that were non-invasive during one to three years of follow-up. It is concluded that sections of fresh-frozen tissues or sections processed in the absence of glycolipid-extracting solvents should be used for visualising the expression of blood group antigens in bladder tissues and assessing their value as prognosticators of the malignant potential of bladder tumours.

Full text

PDF
873

Images in this article

876Image
on p.876
877Image
on p.877
878Image
on p.878
879Image
on p.879
880Image
on p.880
881Image
on p.881

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes R., Hadley H., Dick A., Johnston O., Dexter J. Changes in grade and stage of recurrent bladder tumors. J Urol. 1977 Jul;118(1 Pt 2):177–178. doi: 10.1016/s0022-5347(17)57940-9. [DOI] [PubMed] [Google Scholar]
  2. Bishop M. C. Blood group antigens and bladder cancer. Br Med J (Clin Res Ed) 1982 May 15;284(6327):1426–1427. doi: 10.1136/bmj.284.6327.1426-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. COOMBS R. R., BEDFORD D., ROUILLARD L. M. A and B blood-group antigens on human epidermal cells demonstrated by mized agglutination. Lancet. 1956 Apr 21;270(6921):461–463. doi: 10.1016/s0140-6736(56)90528-1. [DOI] [PubMed] [Google Scholar]
  4. Catalona W. J. Practical utility of specific red cell adherence test in bladder cancer. Urology. 1981 Aug;18(2):113–117. doi: 10.1016/0090-4295(81)90417-9. [DOI] [PubMed] [Google Scholar]
  5. Coon J. S., Weinstein R. S. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am J Clin Pathol. 1981 Aug;76(2):163–171. doi: 10.1093/ajcp/76.2.163. [DOI] [PubMed] [Google Scholar]
  6. Coon J. S., Weinstein R. S. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am J Clin Pathol. 1981 Aug;76(2):163–171. doi: 10.1093/ajcp/76.2.163. [DOI] [PubMed] [Google Scholar]
  7. Coon J. S., Weinstein R. S., Summers J. L. Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol. 1982 Jun;77(6):692–699. doi: 10.1093/ajcp/77.6.692. [DOI] [PubMed] [Google Scholar]
  8. Coon J. S., Weinstein R. S. Variability in the expression of the O(H) antigen in human transitional epithelium. J Urol. 1981 Mar;125(3):301–306. doi: 10.1016/s0022-5347(17)55016-8. [DOI] [PubMed] [Google Scholar]
  9. Cooper H. S., D'Elia F. L. Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma. Am J Clin Pathol. 1982 May;77(5):548–554. doi: 10.1093/ajcp/77.5.548. [DOI] [PubMed] [Google Scholar]
  10. D'Elia F. L., Cooper H. S., Mulholland S. G. ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: correlation with biological behavior. J Urol. 1982 Apr;127(4):665–667. doi: 10.1016/s0022-5347(17)53982-8. [DOI] [PubMed] [Google Scholar]
  11. Feizi T. Blood group antigens and gastric cancer. Med Biol. 1982 Feb;60(1):7–11. [PubMed] [Google Scholar]
  12. Feizi T. The blood group Ii system: a carbohydrate antigen system defined by naturally monoclonal or oligoclonal autoantibodies of man. Immunol Commun. 1981;10(2):127–156. doi: 10.3109/08820138109050693. [DOI] [PubMed] [Google Scholar]
  13. Fujita J., Matsumoto K., Kishi K., Ishiyama I. Synthesis of ABH blood group substances in bladder tumours. Br J Urol. 1981 Oct;53(5):448–452. doi: 10.1111/j.1464-410x.1981.tb03228.x. [DOI] [PubMed] [Google Scholar]
  14. Johnson G. D., Nogueira Araujo G. M. A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods. 1981;43(3):349–350. doi: 10.1016/0022-1759(81)90183-6. [DOI] [PubMed] [Google Scholar]
  15. KAY H. E., WALLACE D. M. A and B antigens of tumors arising from urinary epithelium. J Natl Cancer Inst. 1961 Jun;26:1349–1365. [PubMed] [Google Scholar]
  16. Kapadia A., Feizi T., Evans M. J. Changes in the expression and polarization of blood group I and i antigens in post-implantation embryos and teratocarcinomas of mouse associated with cell differentiation. Exp Cell Res. 1981 Jan;131(1):185–195. doi: 10.1016/0014-4827(81)90418-3. [DOI] [PubMed] [Google Scholar]
  17. Kapadia A., Feizi T., Jewell D., Keeling J., Slavin G. Immunocytochemical studies of blood group A, H, I, and i antigens in gastric mucosae of infants with normal gastric histology and of patients with gastric carcinoma and chronic benign peptic ulceration. J Clin Pathol. 1981 Mar;34(3):320–337. doi: 10.1136/jcp.34.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lange P. H., Limas C. Tissue blood group antigen testing in transitional cell carcinoma of the bladder. J Urol. 1980 Aug;124(2):304–304. doi: 10.1016/s0022-5347(17)55421-x. [DOI] [PubMed] [Google Scholar]
  19. Lange P. H., Limas C. Tissue blood group antigen testing in transitional cell carcinoma of the bladder. J Urol. 1980 Aug;124(2):304–304. doi: 10.1016/s0022-5347(17)55421-x. [DOI] [PubMed] [Google Scholar]
  20. Limas C., Lange P. A, B, H antigen detectability in normal and neoplastic urothelium. Influence of methodologic factors. Cancer. 1982 Jun 15;49(12):2476–2484. doi: 10.1002/1097-0142(19820615)49:12<2476::aid-cncr2820491211>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  21. Limas C., Lange P. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved. Cancer. 1980 Sep 15;46(6):1366–1373. doi: 10.1002/1097-0142(19800915)46:6<1366::aid-cncr2820460613>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  22. Sadoughi N., Mlsna J., Guinan P., Rubenstone A. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma. Urology. 1982 Aug;20(2):143–146. doi: 10.1016/0090-4295(82)90344-2. [DOI] [PubMed] [Google Scholar]
  23. Stein B. S., Kendall A. R. Blood group antigens and bladder carcinoma: a perspective. Urology. 1982 Sep;20(3):229–233. doi: 10.1016/0090-4295(82)90627-6. [DOI] [PubMed] [Google Scholar]
  24. Szulman A. E. Chemistry, distribution, and function of blood group substances. Annu Rev Med. 1966;17:307–322. doi: 10.1146/annurev.me.17.020166.001515. [DOI] [PubMed] [Google Scholar]
  25. Szulman A. E. Chemistry, distribution, and function of blood group substances. Annu Rev Med. 1966;17:307–322. doi: 10.1146/annurev.me.17.020166.001515. [DOI] [PubMed] [Google Scholar]
  26. Watkins W. M. Biochemistry and Genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet. 1980;10:1-136, 379-85. doi: 10.1007/978-1-4615-8288-5_1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES